MedTrace Logo

Longitudinal Evaluation of Active-Duty Personnel with Accessory Pathways (LEAD-AP)

NCT06798961 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-03-14

No results posted yet for this study

Summary

The investigators propose a secondary chart review using EMR data to identify risk factors for sudden cardiac death in active-duty members diagnosed with an accessory pathway between the ages of 18-40.

Conditions

  • Cardiac Death
  • Cardiac Death, Sudden
  • Wolf Parkinson White Syndrome

Interventions

PROCEDURE

Ablation

Patient treated with an ablation to eliminate the accessory conduction pathway in the heart.

PROCEDURE

Standard of care without ablation

Patient diagnosed with accessory pathway but elected against cardiac ablation as a treatment option at the time of diagnosis.

Sponsors & Collaborators

  • United States Naval Medical Center, San Diego

    lead FED

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06798961 on ClinicalTrials.gov